Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Charu Aggarwal, MD, MPH

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-207
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-6318
Fax: 215-349-5326
Lady Hardinge Medical College, New Delhi, India, 2003.
MPH (Health Care Organization and Policy)
University of Alabama at Birmingham, 2005.
Post-Graduate Training
Internship in Internal Medicine, State University of New York, 2005-2006.
Residency in Internal Medicine, State University of New York, 2006-2008.
Fellowship in Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2008-2011.
Chief Fellow, Hematology-Oncology, Temple University-Fox Chase Cancer Center, 2010-2011.
American Board of Internal Medicine: Internal Medicine, 2008.
American Board of Internal Medicine: Medical Oncology , 2011.
American Board of Internal Medicine: Hematology , 2011.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Aggarwal C, Cohen RB, Yu E, Hwang WT, Bauml JM, Alley E, Evans TL, Langer CJ: Etirinotecan Pegol (NKTR-102) in the third line treatment of patients with metastatic or recurrent non-small cell lung cancer: results of a phase II study Clinical Lung Cancer October 2017.

Kesarwala AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, Cengel KA, Evans T, Aggarwal C, Cohen RB, Langer CJ, Rengan R, Simone CB II: The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Prior to Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. Clinical Lung Cancer October 2017.

Aggarwal C, Wang X, Ranganathan A, Torigian D, Troxel A, Evans TL, Cohen RB, Vaidya B, Rao C, Connelly M, Vachani S, Langer CJ, Albelda SM: Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. Lung Cancer 112: 118-125, October 2017.

Bauml J, Kim J, Zhang X, Aggarwal C, Cohen RB, Schmitz K: Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone? Journal of Cancer Survivorship 11(4): 462-468, August 2017.

Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer CJ, Cohen RB, Simone CB: Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer. Cancer July 2017.

Aggarwal C, Borghaei H: Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design. The Oncologist 22(6): 700-708, June 2017.

Thompson JC, Yee SS, Troxel AB, Savitch SL, Fan R, Balli D, Lieberman DB, Morrissette JD, Evans TL, Bauml J, Aggarwal C, Kosteva JA, Alley E, Ciunci C, Cohen RB, Bagley S, Stonehouse-Lee S, Sherry VE, Gilbert E, Langer CJ, Vachani A, Carpenter EL: Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA. Clinical cancer research : an official journal of the American Association for Cancer Research 22(23): 5772-5782, December 2016.

Schapira MM, Aggarwal C, Akers S, Aysola J, Imbert D, Langer C, Simone CB, Strittmatter E, Vachani A, Fraenkel L: How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making. Annals of the American Thoracic Society 13(11): 1969-1976, November 2016.

Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L: Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer. New England Journal of Medicine April 2015.

Bagley SJ, Vitale S, Zhang S, Aggarwal C, Evans TL, Alley EW, Cohen RB, Langer CJ, Blair IA, Vachani A, Whitehead AS: Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer. Clinical lung cancer October 2016.

Aggarwal C, Redman M, Lara P, Borghaei H, Hoffman PC, Bradley JD, Griffin K, Miao J, Mack PC, Papadimitrakopoulou V, Herbst RS, Kelly K, Gandara DR: Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGF pathway-activated stage IV squamous cell lung cancer(SqNSCLC): LUNG-MAP sub-study SWOG S1400D. Journal of Clinical Oncology 35(15_suppl): 9055-9055, May 2017.

Aggarwal C, Cohen RB, Morrow MP, Kraynyak K, Bauml J, Weinstein G, Boyer J, Yan J, Mangrolia D, Oyola S, Duff S, Weiner DB, Csiki I, Bagarazzi ML : Immunotherapy with INO-3112 (HPV16 / HPV18 plasmids + IL-12 DNA) in Human Papillomavirus associated Head and Neck Squamous Cell Carcinoma. Annual Meeting Abstracts, EUROGIN 2017 October 2017.

back to top
Last updated: 04/17/2018
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration